Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Revisiting Ginsberg and Rubinstein's study.

The Journal of thoracic and cardiovascular surgery

Date H.
PMID: 28625774
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1109. doi: 10.1016/j.jtcvs.2017.05.030. Epub 2017 May 18.

No abstract available.

Cite
Date H. Revisiting Ginsberg and Rubinstein's study. J Thorac Cardiovasc Surg. 2017;154(3):1109doi: 10.1016/j.jtcvs.2017.05.030.
Date, H. (2017). Revisiting Ginsberg and Rubinstein's study. The Journal of thoracic and cardiovascular surgery, 154(3), 1109. https://doi.org/10.1016/j.jtcvs.2017.05.030
Date, Hiroshi. "Revisiting Ginsberg and Rubinstein's study." The Journal of thoracic and cardiovascular surgery vol. 154,3 (2017): 1109. doi: https://doi.org/10.1016/j.jtcvs.2017.05.030
Date H. Revisiting Ginsberg and Rubinstein's study. J Thorac Cardiovasc Surg. 2017 Sep;154(3):1109. doi: 10.1016/j.jtcvs.2017.05.030. Epub 2017 May 18. PMID: 28625774.
Copy Download .nbib Format: NLM
Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Sharpnack MF, Ranbaduge N, Srivastava A, Cerciello F, Codreanu SG, Liebler DC, Mascaux C, Miles WO, Morris R, McDermott JE, Sharpnack JL, Amann J, Maher CA, Machiraju R, Wysocki VH, Govindan R, Mallick P, Coombes KR, Huang K, Carbone DP.
PMID: 30017829
J Thorac Oncol. 2018 Oct;13(10):1519-1529. doi: 10.1016/j.jtho.2018.06.025. Epub 2018 Jul 11.

INTRODUCTION: Despite apparently complete surgical resection, approximately half of resected early-stage lung cancer patients relapse and die of their disease. Adjuvant chemotherapy reduces this risk by only 5% to 8%. Thus, there is a need for better identifying who...

Cite
Sharpnack MF, Ranbaduge N, Srivastava A, et al. Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma. J Thorac Oncol. 2018;13(10):1519-1529doi: 10.1016/j.jtho.2018.06.025.
Sharpnack, M. F., Ranbaduge, N., Srivastava, A., Cerciello, F., Codreanu, S. G., Liebler, D. C., Mascaux, C., Miles, W. O., Morris, R., McDermott, J. E., Sharpnack, J. L., Amann, J., Maher, C. A., Machiraju, R., Wysocki, V. H., Govindan, R., Mallick, P., Coombes, K. R., Huang, K., & Carbone, D. P. (2018). Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 13(10), 1519-1529. https://doi.org/10.1016/j.jtho.2018.06.025
Sharpnack, Michael F, et al. "Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 13,10 (2018): 1519-1529. doi: https://doi.org/10.1016/j.jtho.2018.06.025
Sharpnack MF, Ranbaduge N, Srivastava A, Cerciello F, Codreanu SG, Liebler DC, Mascaux C, Miles WO, Morris R, McDermott JE, Sharpnack JL, Amann J, Maher CA, Machiraju R, Wysocki VH, Govindan R, Mallick P, Coombes KR, Huang K, Carbone DP. Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma. J Thorac Oncol. 2018 Oct;13(10):1519-1529. doi: 10.1016/j.jtho.2018.06.025. Epub 2018 Jul 11. PMID: 30017829; PMCID: PMC7135954.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries